16.30
0.00
(0.00%)
As of 5:00:01 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 6 | 8 | 8 |
| Avg. Estimate | 268.65M | 257.95M | 989.5M | 1.09B |
| Low Estimate | 268.1M | 250.2M | 988.9M | 1.05B |
| High Estimate | 269.4M | 268.19M | 990.15M | 1.13B |
| Year Ago Sales | 234.26M | 227.47M | 924.37M | 989.5M |
| Sales Growth (year/est) | 14.68% | 13.40% | 7.05% | 9.73% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 6VY.F | -- | -- | -- | -- |
| S&P 500 | 9.39% | 11.29% | 14.06% | 13.54% |
Upgrades & Downgrades
| Upgrade | Morgan Stanley: Equal-Weight to Overweight | 12/13/2024 |
| Upgrade | B of A Securities: Neutral to Buy | 12/9/2024 |
| Maintains | Baird: Outperform to Outperform | 11/11/2024 |
| Maintains | Baird: Outperform to Outperform | 11/8/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 9/6/2024 |
| Maintains | Citigroup: Buy to Buy | 8/12/2024 |